PerfuseCell Cronus A/S: Financial statements 2021
CVR: 31606810
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
PerfuseCell Cronus A/S (CVR 31606810) has filed annual accounts for 2021. In 2021, the company reported revenue of DKK 149,944 and a net result of DKK 34,216 compared with DKK 86,806 the year before. That is a decrease of 61.1% compared with the year before. The profit margin was 22.8%. Equity in the 2021 report amounted to DKK 783,883. The solvency ratio was 100%.
- Revenue
- DKK 149,944
- Gross Profit
- DKK 34,216
- Profit/Loss
- DKK 34,216
- Equity
- DKK 783,883
- Total Assets
- DKK 783,883
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | 150 t. | 34 t. | 34 t. | 784 t. | - |
| 2020 | 385 t. | 87 t. | 87 t. | 750 t. | - |
| 2019 | 220 t. | 172 t. | 172 t. | 663 t. | - |
| 2018 | 532 t. | 272 t. | 168 t. | 491 t. | - |
| 2017 | 1.7 mio. | 310 t. | 309 t. | 323 t. | - |
Official annual report
Find more companies like PerfuseCell Cronus A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
PerfuseCell Cronus A/S has published its annual report for 2020. Revenue came to DKK 385,093, and the net result was DKK 86,806.
About PerfuseCell Cronus A/S
PerfuseCell Cronus A/S is a Danish company of the type Aktieselskab based in Herlev, founded in 2008. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The company was previously named PerfuseCell A/S and PumpCell A/S. The management consists of Per Stobbe. The board consists of August Kisling Stobbe, Flemming Petersen and Per Stobbe. The company is owned by Stobbe GmbH. In 2025, the company reported a gross profit of DKK 20,467 and a net result of DKK 23,973 compared with DKK 2,216 the year before. Equity in the 2025 report amounted to DKK 1,070,836.